 Biondvax Pharmaceuticals Ltd - ADR NASDAQ: BVXV shares are trading higher by 32.1 at 1.81 after the company announced it signed a definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody therapies. BiondVax says the company is planning a rapid. 